Hofseth BioCare: Funding, Investors & Team (Sep 2026)
Hofseth BioCare's key goal is to offer high benefit added biomarine elements for human applications. Through inventive creation innovation and coordinated factors, they safeguard the nature of protein, calcium and oil extricated from fish. This innovation is exclusive to their organization.
Hofseth BioCare has raised $33.0M across 3 funding rounds on record, the most recent an undisclosed round of $14.6M announced in Jun 2026.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Hofseth BioCare Company Profile and Key Stats
Latest funding round on record: Jun 2026.
Hofseth BioCare Funding Rounds
Hofseth BioCare raised $14.2M in a Post-IPO Equity announced in Jul 2022.
2.8 years later, an undisclosed round of $4.2M was announced in May 2025.
1.1 years later, an undisclosed round of $14.6M was announced in Jun 2026.
Hofseth BioCare Founders and Leadership Team
Contact details for the Hofseth BioCare team: 1 of 2 have an email address on file.
Start 14-day free trial →Hofseth BioCare Funding Compared to Other Biotechnology Startups
Hofseth BioCare's latest round of $14.6M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Hofseth BioCare in Biotechnology and Ålesund
Companies Similar to Hofseth BioCare
Zelluna Immunotherapy AS is a privately owned Norwegian biopharmaceutical company founded in 2016 focused on…
Circio Holding ASA is a company in the clinical stage that is developing immune activators for challenging…
IDEX, a biometrics software and fingerprint authentication company based in Oslo, Norway, was established in…
Arctic Bioscience is a biotechnology research company that develops products, solutions, and technologies…
Lytix Biopharma AS is a privately-owned pharmaceutical company focussed on anti-microbials and cancer…
Actithera is a company specializing in developing radioligand therapies through the application of medicinal…
NoMy is a company focused on creating sustainable and scalable solutions for alternative proteins by…
Oncoinvent AS designs and develops cancer treatments by applying known physical and chemical principles of…
Biosergen AS develops variants of nystatin with improved properties. Its pipeline products include S44HP, an…
NEXT offers secure and user-friendly fingerprint sensor technology for verification purposes in various…
We are a speciality pharmaceutical business committed to the creation and marketing of goods for people who…
Calluna has developed a robust pipeline of selective antibodies, targeting immunological diseases. These…
Hofseth BioCare Funding FAQs
What does Hofseth BioCare do?
Hofseth BioCare's key goal is to offer high benefit added biomarine elements for human applications. Through inventive creation innovation and coordinated factors, they safeguard the nature of protein, calcium and oil extricated from fish. This innovation is exclusive to their organization.
How much funding has Hofseth BioCare raised?
Hofseth BioCare has raised $33.0M across 3 rounds on record. The most recent is an undisclosed round of $14.6M announced in Jun 2026.
When did Hofseth BioCare last raise funding?
Hofseth BioCare's most recent funding round on record is an undisclosed round of $14.6M, announced in Jun 2026.
Who founded Hofseth BioCare?
FundedIQ lists Jon Olav (Founder), Roger Hofseth (Founder) at Hofseth BioCare.
Where is Hofseth BioCare headquartered?
Hofseth BioCare is based in Ålesund, More Og Romsdal, Norway.
How many employees does Hofseth BioCare have?
Hofseth BioCare is in the 11-50 employee band.
How does Hofseth BioCare's funding compare to other Biotechnology startups?
Hofseth BioCare's latest round of $14.6M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Hofseth BioCare Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Hofseth BioCare is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.